IBTFvsPPH
iShares iBonds Dec 2025 Term Treasury ETF against VanEck Pharmaceutical ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| IBTF | PPH | |
|---|---|---|
| Expense ratio | 0.070% | 0.36% |
| Assets | $1.4B | $1B |
| Net flow, 1 month | — | +$22M |
| Net flow, 1 year | −$367M | +$308M |
| Return, YTD | — | +4.8% |
| Return, 1 year | 0.0% | +15.4% |
| Avg daily volume | — | 294K |
| Holdings | 32 | 27 |
| Listed | Feb 25, 2020 | Feb 1, 2000 |
| Options market | No | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS